跳至主要内容
临床试验/NCT07053176
NCT07053176Enrolling By Invitation4 期

Usefullnes of Local Lidocaine Paravertebral Cervical Injection on Cervicogenic Dizziness Symptoms Management: a Randomzied Clinical Trial

Uniter Onlus1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2025年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
Enrolling By Invitation
发起方
入组人数
42
试验地点
1
主要终点
Dizziness Handicap Inventory

研究概览

简要总结

at least 42 patients affected by cervicogenic dizziness will be allocated to the experimental group or in the placebo group. in the first group patients will received 2 paravertebral intramuscular injection of lidocaine 0.5% while in the placebo group they will received saline solution with the same injection technique. patients will be evaluated by subjective and objective testing before the treatment, immediatly and 3 months after the treatment.

详细描述

at least 42 patients affected by cervicogenic dizziness will be allocated to the experimental group or in the placebo group. in the first group patients will received 2 paravertebral intramuscular injection of lidocaine 0.5% while in the placebo group they will received saline solution with the same injection technique. patients will be evaluated by subjective and objective testing before the treatment, immediatly and 3 months after the treatment. subjective testing will include dizziness handicap inventory, Neck Disability Index, Neck Pain Intensity, Tampa Scale for Kinesiophobia, Hospital Anxiety and Depression Scale. Objective testing will include cervical range of motion, joint position error and static posturography testing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •presence of a subjective feeling of dizziness associated with pain, movement, rigidity, or certain positions of the neck at least from 3months; 2) Cervical pain, trauma, and/or disease (3) If from traumatic origin, there has to be a temporal proximity between the onset of dizziness and the neck injury.

排除标准

  • •Exclusion of these differential diagnoses: (a) Migrainous vertigo (b) Vertigo of central origin (c) Benign paroxysmal positional vertigo (d) Meniere disease (e) Vestibular neuritis (f) Vertigo induced by drugs (g) Psychogenic vertigo (anxiety and/or panic disorder and/or phobia) (h) Orthostatic hypotension
  • •presence of trauma or recent surgery in the head, face, neck, or chest; an otorhinolaryngological diagnosis of central or peripheral vertigo, and receiving physiotherapy or other treatment during the study period.
  • •allergy to lidocaine

研究组 & 干预措施

Lidocaine

Experimental

patients will received lidocaine paravertebral injection

干预措施: 0.5% Lidocaine (Drug)

Sham

Placebo Comparator

patients will received saline solution paravertebral injection

干预措施: Saline Solution (NaCl 0,9%) (Drug)

结局指标

主要结局

Dizziness Handicap Inventory

时间窗: one monthe

Dizziness Handicap Inventory version comprises 25 questions designed to assess a patient's functional (9 questions), emotional (9 questions), and physical (7 questions) limitations on a three-point scale, with higher scores reflecting greater perceived handicap

次要结局

  • Neck Disability Index(one month)
  • Neck Pain Intensity(one month)
  • Tampa Scale for Kinesiophobia(one month)
  • Hospital Anxiety and Depression Scale.(one month)
  • The 36-item short form survey (SF-36)(one month)
  • Cervical range of motion(one month)
  • Static posturography testing(one month)
  • Cervical relocation test (CRT)(one month)

研究者

发起方
Uniter Onlus
申办方类型
Other
责任方
Principal Investigator
主要研究者

Alessandro Micarelli

UNITER ONLUS

Uniter Onlus

研究点 (1)

Loading locations...

相似试验